المؤلفون: Yong, Yu, Liang, Jing, Yang, Nan, Xiao, De-Yuan, Jiang, Jian-Peng, Guo, Jing-Rui, Wang, Ling-Fei, Geng, Di, Ba, Lan-Song, Liang, Hong-Gang, Lu, Ya-Nan, Wang, Dan, Li, Yu-Ke, Yin, Xiao-Ming, Huang, Long, Shi, Jiang-Liu, Wang, Gui-Lei, Tang, Yan-Zhe, Li, Hong-Wen, Kang, Bryan, Yoo, Abraham, Cao, Kan-Yu, Li, Ling, Zhao, Chao

المصدر: 2022 IEEE 16th International Conference on Solid-State & Integrated Circuit Technology (ICSICT) Solid-State & Integrated Circuit Technology (ICSICT), 2022 IEEE 16th International Conference on. :1-3 Oct, 2022

Relation: 2022 IEEE 16th International Conference on Solid-State & Integrated Circuit Technology (ICSICT)

المؤلفون: Guo, Jing Rui, Zheng, Xian Chang, Zhang, Ji Qing, Zhao, Zhi Meng

المصدر: Advanced Materials Research; March 2018, Vol. 1145 Issue: 1 p8-16, 9p

المؤلفون: Jian XD; Department of Rheumatology and Occupational Medicine, Qilu Hospital of Shandong University, Jinan 250012, China., Guo GR, Ruan YJ, Wang YC, Ning Q, Zhao B, Gao DM, Li P, Feng FR, Guo JR, Wang X, Lin DW, Sun G

المصدر: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases [Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi] 2008 Sep; Vol. 26 (9), pp. 549-52.

نوع المنشور: English Abstract; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Tianjin shi lao dong wei sheng yan jiu suo ; Tianjin shi lao dong wei sheng huan jing yi xue hui Country of Publication: China NLM ID: 8410840 Publication Model: Print Cited Medium: Print ISSN: 1001-9391 (Print) Linking ISSN: 10019391 NLM ISO Abbreviation: Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Paraquat/*poisoning , Poisoning/*drug therapy, Acute Disease ; Adolescent ; Adult ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Drug Therapy, Combination ; Etanercept ; Female ; Humans ; Immunoglobulin G/administration & dosage ; Immunoglobulin G/therapeutic use ; Male ; Methylprednisolone/administration & dosage ; Methylprednisolone/therapeutic use ; Middle Aged ; Receptors, Tumor Necrosis Factor/administration & dosage ; Receptors, Tumor Necrosis Factor/therapeutic use ; Treatment Outcome ; Young Adult